Children with recurrent otitis show defective IFN gamma-producing cells in adenoids

Antonietta M Avanzini1, Anna Maria Castellazzi, Massimo Marconi

  • 1Laboratori Sperimentali, Area Trapiantologica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Insights

Children with recurrent ear infections may have a weakened immune response. Their adenoid tissue produces less interferon-gamma (IFN-γ), a key immune protein, increasing susceptibility to infections.

Area of Science:

  • Immunology
  • Pediatrics
  • Otolaryngology

Background:

  • Recurrent infectious diseases in children pose a significant clinical challenge.
  • A compromised immune response is a suspected factor in recurrent pediatric infections.
  • Otitis media is a common recurrent infection in childhood.

Purpose of the Study:

  • To investigate if children with recurrent otitis exhibit impaired interferon-gamma (IFN-γ) production.
  • To compare IFN-γ production in peripheral blood and adenoid tissue lymphocytes between children with and without recurrent otitis.

Main Methods:

  • Study included 58 children undergoing adenoidectomy for adenoidal hypertrophy.
  • Participants were categorized into groups based on otitis recurrence (≥3 episodes/year vs. <3 episodes/year).
  • Intracellular cytokine profiles of lymphocyte subsets were analyzed using flow cytometry in adenoid and peripheral blood samples.

Main Results:

  • Children with recurrent otitis demonstrated a significantly lower percentage of CD8+ cells producing IFN-γ in adenoid tissue compared to controls (p = 0.003).
  • No significant differences were noted in peripheral blood lymphocyte IFN-γ production (data not shown in abstract).
  • Adenoid tissue appears to be a critical site for immune dysfunction in recurrent otitis.

Conclusions:

  • Reduced IFN-γ production by adenoid cells may contribute to increased susceptibility to recurrent otitis in children.
  • This finding highlights a potential immune defect in the local adenoid tissue relevant to recurrent ear infections.
  • Targeting local immune responses in adenoids could be a future therapeutic strategy.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...